Company intelligence / Profile preview

Biora Therapeutics

San Diego, California, United Statesbioratherapeutics.com ↗

Ownership: Public · BIOR
Development stage: Other

Overview

Biora Therapeutics has developed two main smart-pill drug delivery platforms—BioJet™ for systemic, needle-free oral delivery of large molecules and NaviCap™ for targeted GI tract drug release. The company’s lead programs include an anti-TNF-alpha monoclonal antibody delivered orally for ulcerative colitis and other autoimmune diseases. As of early 2025, the company completed a court-supervised restructuring, emerged as a private entity with new ownership by major investment funds, and continues to advance its platform technologies with ongoing pharma collaborations. Clinical results are not yet publicly detailed.

Therapeutic areas: GastroenterologyImmunology
Modalities: DeviceBiologicSmall molecule
Industry: Biotech

Drug pipeline

7 assets

enamel matrix derivative

6 more assets in the full pipeline.

Request access →

Partnerships

Pharma collaborators (names undisclosed)

Financials

Market cap: $995K
Total revenue: $32K
Enterprise value: $37.4M

Beyond the preview

Go deeper on Biora Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biora Therapeutics.

Explore the full profile